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CaPB33 and CaPB37, two annexins purtfied from bovine bram, interact wtth a Trtton X-IOO-resistant fractton (cytoskeleton) from bovine brain 
membranes in a Caz+-dependent way m v&o. The binding is saturable wtth respect to the CaBP33CaBP37 concentratron. half-maxIma bmdmg 
occurrmg at _ 15 pg of the CaBP33-CaBP37 mtxture/ml. The binding of these two annexms to the crude cytoskeleton preparation as a functton 
of free Ca*+ concentration IS btphasic. wtth half-maximal bmdmg at c 50 JIM and -400 ;ttM free Cal+ for the first and the second component, 
respecttvely. By an overlay techmque, CaBP33 and CaBP37 bmd to a set of low M, polypepttdes (i&20 kDa) in the crude cytoskeleton preparatton. 
wtth formation of an 85-90 kDa complex as mvesttgated m cross-hnkmg experiments. No bindmg of the CaBP33CaBP37 mtxture to either G- 
or F-actin has been observed Identificdtton of the CaBP33-CaBP37-bmding protems m cytoskeletons would help elucrdatmg the functton(s) of 
these annexms m the brain 
CaBP33-CaBP37, Annexin, Calcmm. Cytoskeleton. Bmdmg 
1. INTRODUCTION 
Two Ca2+-binding proteins purified from bovine 
brain by Ca2+-dependent affinity chromatography on 
phenyl-Sepharose [I] were shown to be Ca’+-dependent 
phospholipid- and membrane-binding proteins [2]. 
Ca’+-dependent phospholipid and membrane-binding 
proteins constitute a novel superfamily of Ca2+-binding 
proteins known as annexins, that have been involved in 
the regulation of the structural organization of 
biological membranes, cell growth, exocytosis and en- 
docytosis, and the inflammatory response (see (3-5) for 
reviews). The two proteins were cahed CaBP33 and 
CaBP37 on the basis of their M, values as estimated by 
sodium dodecyl sulfate polyacrylamide gel elec- 
trophoresis (SDS-PAGE) and gel filtration [ 11. 
These proteins have been analyzed for their sub- 
cellular distribution in bovine brain by an immuno- 
chemical approach [2]. CaBP33 and CaBP37 were 
found soluble in the cytoplasm as well as associated 
with membranes. One fraction of membrane-bound 
CaBP33 and CaBP37 was resistant to EGTA and ex- 
tractable with Triton X-100, and another fraction was 
resistant o Triton X-100 and extractable with high con- 
centrations of EGTA/KCl [2]. While the former frac- 
tion was recovered in the Triton X-lOO-extractable 
material irrespective of the presence or absence of Ca2+, 
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the Triton X-loo-resistant fraction required the 
presence of Ca’+ during the homogenization of brain 
tissue and subsequent steps for it to be recovered [2]. 
The detergent-resistant fraction of membrane-asso- 
ciated CaBP33 and CaBP37 was considered bound to 
membrane-skeleton protein in a Ca2+-dependent way 
PI* 
We have undertaken a study aimed at characterizing 
the binding properties of the CaBP33-CaBP37 mixture 
to a crude cytoskeleton fraction obtained from bovine 
brain membranes, in an attempt to identify the 
molecular target(s) of the two proteins in cytoskeletons. 
2. MATERIALS AND METHODS 
The CaBP33CaBP37 mixture was purifted from bovine bram as m 
[I]. An antiserum against the unfractionated mixture was raised in 
rabbits and characterized as in [2]. Actin was purified from porcine 
heart as in [6]. 
A crude cytoskeleton fraction was obtained from bovine brain as 
follows. Frozen brain tissue (40 g) was thawed and homogenized m 20 
mM Trts-HCI, pH 7.5, 5 mM EGTA, 0.25 mM phen~lmethylsulfonyl 
fluortde (buffer A) (1 : 3, w : v) and centrifuged at 900 x g for 10 mm 
in a Kontron (Centrikon H-401) centrifuge to remove nuclei and cell 
debris. The supernatant was saved and the pellet re-extracted and cen- 
trifuged as above. The two supernatants were combined and cen- 
trifuged at 30 000 x g for 60 mm. The pellet was resuspended in buffer 
A, loaded onto a cushion of 0.8 M sucrose m buffer A and centrifuged 
at 30000 g in a Kontron (Centrikon T 1055) centrtfuge for 45 mm to 
remove myelin. The pellet was washed once in buffer A contaimng 1 
mM, instead of 5 mM, EGTA (buffer B) and resuspended m 230 ml 
of buffer B containing 1% (v: v) Triton X-100. After 60 min under 
agitation, the suspensron was centrifuged at 2OOOWJ g for 60 min The 
pellet was washed twice in buffer B by resuspension and centrifuga- 
tion, and resuspended in buffer B. All operations were done at 4°C. 
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Three procedurer were used to momtor the mteractlon between the 
CaBP33-CaBP37 mtxture with Trlton X-IOO-reslstant (cytorkeleton) 
s P s P s P s P 
protem obtalned a< described above. In one case, the CaBP33- 
CaBP37 mivturc wa> incubated with the crude preparation of bram 
cytosheleton an 0.5 ml of buffer B contacnlng 0.1 M KC?, I mM MgCL> 
(buffer C) In the absence and presence of CaClz for 60 mm at room 
temperature, after which the suspensions were centrlfugrd at 
~50~ i g for 30 min. The supernatants were saved and the pellet+ 
were washed once tn the respecrlve incubation media. The final pellet, 
were resuspended m 0.5 ml of buffer B. Equal portions of mdlvidual 
\upernatants and pellet\ were TubJected to SDS-PAGE. Gel5 were 
rtalned w%h C‘oomatrie blue. Deqtamed gels were subjected to den- 
Gtometry. In tome Instances, protein+ ceparated by SDS-PAGE were 
electroblotted onto mtrocelluloce paper and analyzed for the presence 
of the CaBP33-CaBP37 mixture with the and of the antrKaBP33- 
CaBP37 antrsrrum by the method m [7]. See legends to F~ga. l-4 for 
further detatlr. In the Eerond set of expertmentz, the CaBP33-CaHP37 
mixture was incubated wnh the crude preparatmn of brain cyto- 
skeleton as above m 75 ~1 of buffer C (final volume) in the absence 
and oreqence of different concentrations of CaClz for 60 min. after 1 2 3 4 5678 
which the bifunctional cross-hnker dlsuccinimldyl suberate (DSS) was 
added to 0 5 mM for 5 mln at room temperature The reaction wa( 
terminated by addmg SDS and 2-mcrcaptoethanol to 2%. Samples 
were subjected to SDS-PAGE and immunoblottmg as described 
above. In the third ket of euperlments, sample\ of the crude pre- 
paration of bram cytoskeleton were subjected to SDS-PAGE and 
eiectrobl~~tted onto nltroc~~lulose paper. ~~embranes were then in- 
cubated at 37°C for 60 mm m buffer C containing 3% (\v : v) bovine 
serum albumin (BSAJ (buffer D) in the absence and presence of 
CaClz, and then with 10 pg of the CaHP33-CaBP37 mluture/ml of 
buffer D in the absence and presence of CaCIZ, respectively. for 4 h 
at room temperature. Membranes were washed 3 times. 5 mm each. 
m the respective incubation buffer minus BSA, and subjected to Im- 
munoblottmg as above. b’ashmgs between steps were done as above. 
SDS-PAGE (10% acrylamide) war done as m IS]. Protein was 
measured as in [9]. The immune reaction on n~troceliulose paper was 
evidenced by 0.3 mg of dtamme benzjdine~mi of 50 m?J Tm-HCI, pH 
7.5, contammg 0.02% f+ : +I Hz&. 
FIN, 1 Ca”-dependent mteractlon of the CaBP33-CaBP37 mixture 
with bovine braln cytoakeletonf Cytoskelrton protein (150 pg) was 
incubated with lO/cp of the CaBP33-CaBP37 mixture in 0.5 ml of 20 
mhl Trts-HCI, pH 7.5, 0 1 hl KCI, I mhl XlgCI:, I mM EGTA in the 
absence and presence of - 1 mM free Ca” and further proceased as 
described in section 2. Identxai vols of the supernatants (s) and pellets 
(p) were subjected to SDS-PAGE. (Lanes I,21 The CaBP33-CaBP37 
mixture was incubated m the presence of Ca” and absence of 
cqto,keleton protem (3-6) The CaBP33-CaBP37 mixture was in- 
cubated with cyto&eleton protein m the absence (lanes 3,4) and 
presence (lanes 5.6) of Ca”. (7,8) Conditions were as in lanes 5,6, ex- 
cept that the mcubatlon mixture received EGTA to 5 mM after 60 mm 
of incubation. Note that the two annexmh cosedunent, I.e. interact, 
with cytoskeleton protein m a Ca”-dependent way and that the bm- 
dmp is fully reversed by the final addttron of EGTA 
3. RESULTS AND DISCUSSION 
presence of Cal+ (Fig. I). These data indicated that the 
two proteins bind to brain cytoskeletons in a 
Ca’+-dependent way and that the bindinn is raDidlv 
The binding of the CaBP33-CaBP37 mixture to the 
crude cytoskeleton preparation obtained as described in 
section 2 was studied by a sedimentation assay, follow- 
ed by SDS-PAGE of supernatants and pellets. This pro- 
cedure could be employed since we verified that the 
crude cytoskeleton preparation did not contain en- 
dogenous CaBP33 and CaBP37 (EGTA was present 
throughout), as investigated by both SDS-PAGE and 
immunoblotting (see Fig. 1, lane 4, and Fig. 5, lanes 7 
and 8), in accordance with previous observations [2]. 
No cosedimentation of the CaBP33-CaBP37 mixture 
with cytoskeleton protein was detected in the absence of 
Ca’+, whereas significant cosedimentation of the two 
proteins was observed in the presence of 1 mM free 
Ca’+ (Fig. 1). About 5% of the CaBP33-CaBP37 mix- 
ture sedimented in the presence of 1 mM free Ca’+ and 
absence of cytoskeletons (Fig. 1). No such Ca’+-de- 
pendent, cytoskeieton-independent sedimentation of 
the two proteins was seen in 100 FM free Ca2+ (not 
shown). Cosedimentation, i.e. interaction, of the two 
proteins with cytoskeletons was abolished when EGTA 
had been added to samples of cytoskeletons previously 
incubated with the CaBP33-CaBP37 mixture in the 
. _ 
reversed-by Ca”-chklators. The extent of CaBP33 and 
CaBP37 binding to cytoskeletons in the presence of 
Cal’ increased with increasing concentrations of 
c~oskeleton protein (Fig. 2). At I mM free Ca*+, the 
binding of the CaBP33-CaBP37 mixture as a function 
of the CaBP33-CaBP37 concentration was maximal at 
- 30 pg/ml and half-maximal at - 15 pg/ml (Fig. 3). 
By densitometry, the CaBP33-CaBP37 mixture con- 
tained nearly equal amounts of individual proteins. 
This was also true for cytoskeleton-bound CaBP33- 
CaBP37 in the present assay. On the basis of these 
observations, assuming an average M, value of 35 kDa 
for the mixture, half-maximal binding occurred at 
- 0.45 pM, that represents an approximate measure of 
the binding affinity. No attempt was done to construct 
a Scatchard plot of these data, since no CaBP33- 
CaBP37 mixture could be seen in SDS gels of the super- 
natants relative to the first four experimental points, 
i.e. from 2 to 8 ag of the mixture/ml (Fig. 3). In other 
words, no precise measurement of the unbound protein 
could be done as far as the first four experimental 
points were concerned, which hampered a correct cal- 
culation of the bound/free ratios. Nevertheless. it is 
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Fig. 2. Binding of the CaBP33XaBP37 mixture to brain cytoskeleton 
protein as a function of cytoskefeton protein concentration. Increas- 
ing amounts of cytoskeleton protein were incubated with 15 pg of the 
CaBP33-CaBP37 mixture in the presence of - 1 mM free Ca” under 
the condition detailed in Fig. 1. Individual supernatants (s) and 
pellets (p) were analyzed by SDS-PAGE. Cytoskeleton protein ‘*Ias 
100 /~g (lanes 1,2), 200 pg (3,4) and 400 pg (5,6). 
clearly evident from data in Fig. 3 that a very large 
proportion of the CaBP33-CaBP37 mixture had cosedi- 
mented with cytoskeletons at the very low CaBP33- 
CaBP37 concentrations, strongly suggesting that the 
binding affinity of the mixture to cytoskeletons is much 
higher than 0.45 ,LLM, and that individual CaBP33 and 
CaBP37 bind to cytoskeletons with at least two dif- 
ferent affinities. This would anticipate that more than 
one target exists for individual CaBP33 and CaBP37 in 
cytoskeletons. Of course, a precise analysis of this 
point could be done by performing experiments of 
binding of radiolabeled individual CaBP33 and 
CaBP37 to cytoskeletons. 
The binding of the CaBP33-CaBP37 mixture to brain 
cytoskeletons was also studied as a function of free 
Ca2+ concentration. The extent of binding was biphasic 
(Fig. 4). A first component was saturated at - 100rM 
free Ca2+ and half-maximal at - 50 yM free Cat + , and 
a second component was maximal at - 1 mM free 
Ca’+. 
On the basis of the findings illustrated so far, and in 
consideration that some members of the annexin super- 
family, e.g. the heavy chain (~36) of the cytoskeletal 
protein complex calpactin I and a 73 kDa annexin 
found in human lymphoc~es, monocytes, liver, and 
placenta and in rat adrenal medulla [lo,111 bind to F- 
actin, we sought to determine whether or not the 
CaBP33-CaBP37 mixture was capable of binding to F- 
actin. By a sedimentation assay, no binding of the mix- 
S 
12345678910 
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Fig. 3. Bmding of the CaBP33-CaBP37 mixture to brain cytoskeleton 
protein as a function of CaBP33-CaBP37 concentration. Cyto- 
skeleton protein (150 fig) was incubated m the presence of - 1 mM 
free Ca’+ with 1. 2, 3, 4, 5, 7.5, 10, 15, 20, 30 pg of the 
CaBP33-CaBP37 mixture (lanes I-10, respectively) under the condi- 
tions described in Fig. 1. Individual supernatants (s) and pellets (p) 
were analyzed by SDS-PAGE. 
ture was observed to F-actin irrespective of the presence 
(Fig. 5, lanes 1 and 2) or the absence (not shown) of 
Ca’+. Thus these two annexins are not ‘calpactins’. 
To have preliminary information on the molecular 
target(s) of the CaBP33-CaBP37 mixture in brain 
cytoskeletons, cross-linking experiments were perform- 
ed as described in section 2. Complex formation be- 
tween the CaBP33-CaBP37 mixture and cytoskeleton 
protein was investigated by immunoblotting. In the 
absence of Ca2+, irrespective of the presence (Fig. 5, 
lane 3) or absence (not shown) of cytoskeleton protein, 
a broad CaBP33-CaBP37 immunoreactive species was 
seen at - 70 kDa, besides the expected immunoreactive 
species at 33 and 37 kDa, suggesting that DSS had 
cross-linked CaBP33 and/or CaBP37 molecules to one 
another to some extent. When the binding reaction was 
done in the presence of 1 mM free Ca*+, a broad im- 
munoreactive species was seen at 85-90 kDa (Fig. 5, 
lane 4). Only a slight immunoreactivity was observed at 
the - 70 kDa level under these conditions. The forma- 
tion of the 85-90 kDa immunoreactive species was thus 
dependent on Ca2+, as also indicated by the fact that 
the final addition of EGTA to 5 mM to samples of 
cytoskeleton protein incubated with the CaBP33- 
CaBP37 mixture in the presence of 1 mM free Ca2+ pro- 
173 
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duced the disappearence of the 85-90 kDa species 
(Fig. 5, lane 5). Results identical to those illustrated in 
Fig. 5, lane 4, were obtained when the binding reaction 
had occurred at 0.1 mM free Ca’+ (Fig. 5, lane 6). 
When either pure G-actin or F-actin was used in cross- 
linking experiments, no specific complex formation was 
evidenced (not shown), in accordance with the lack of 
cosedimentation of the CaBP33-CaBP37 mixture with 
F-actin documented in Fig. 5, lanes 1 and 2. 
6 5 4 3 
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Direct information on the molecular species in brain 
cytoskeletons with which the CaBP33-CaBP37 mixture 
interacted was obtained by an overlay procedure. fn 
Fig. 4. Binding of the CaBP33-CaBP37 mixture to brain cytoskerrturr 
protein as a function of the free Ca”’ concentratron. Cytoskeleton 
protein (150 pg) was incubated with 15 pg of the CaBP33-CaBP37 
mixture under the conditions described in Ftg. I in the presence of in- 
creasing concentrations of free Cal’ as indicated. Indrviduai pellets 
were SubJected to SDS-PAGE. Destained gels were analyzed by den- 
sitometry. The peak areas of the CaBP33-CaBP37 mrxture m pellets 
were plotted as a function of the free Ca” concentration (pCa). The 
peak area at - 1 mM free Ca”+ was taken as 1OOoio. 
this case, in the presence (Fig. 5, lane 7), but not in the 
absence (Fig. 5, lane 8) of Cazt, CaBP33-CaBP37 im- 
mune reactivity was seen at the level of 4 polypeptides 
of M, values ranging from - 10 to - 20 kDa and, to 
a much smaller extent, at the level of an - 110 kDa 
polypeptide. We cannot exclude the possibility that 
other CaBP33-CaBP37-binding polypeptides in the 
brain cytoskeleton preparation used in the present study 
S P 
Fig. 5. Analysis of the molecular targets of the CaBP33-CaBP37 mixture in brain cytoskeletons. (Lanes 1,2) Porcine heart actm (200 ag) was 
poIymerized in 0.5 ml of 20 mM Tris-HCI, pH 7.5, 0.1 M KCl, 1 mM MgC12, 0.2 mM ATP, 1 mM EGTA, 1 mM free Ca”, 10 pg of the 
CaBP33-CaBP37 mixture at room temperature for 60 min, and centrifuged at 100000 xg for 60 min. The supernatant was saved. The pellet was 
washed once m the polymerization buffer and resuspended in 0.5 ml of buffer B. Identical vois of the supernatant (s) and pellet (p) were analyzed 
by SDS-PAGE. Note that the two annexins do not cosedrment with F-actin. Identical results were obtained in the absence of Ca” (not shown). 
Also, increasing the G-actin concentration to 4 mg/ml dtd not result in cosedimentation of the two annexins with F-actm (not show@. No effect 
of the two annexins was seen on the extent of actin polymerization (not shown). (3-6) Cross-linkmg experiments. The CaBP33-CaBP37 mixture 
(IO ag) was incubated with 15OGg of cytoskeleton protein in 75 ~1 of the incubation buffer described m section 2 m the absence of CaClz (3), in 
the presence of - 1 mM free CaZ’ (4). in the presence of - 1 mM free Ca”+ followed by the addition of 5 mM EGTA (5), and in the presence of 
- 0.1 mM free Ca’+ (6) for 60 min at room temperature. Samples then received DSS to 0.5 mM for 5 mm, followed by SDS and 2-mercaptoethanol 
to 2% before SDS-PAGE. Proteins so separated were electroblotted onto nitrocellulose paper and subjected to ~mmunoblotting using the rabbit 
anti-CaBP33-CaBP37 antiserum [Z]. The tripte asterisk points to the position of the uncomplexed annexms. the double asterisk to the position of 
the annexins cross-linked to cytoskeleton polypeptides, and the single asterisk to the positron of the two annexms cross-linked to one another. No 
cross-linking of the two annexins to one another was seen m the absence of DSS (not shown). (7,s) Overlay expertments. Cytorkeleton protein 
(230 pg) was subjected to SDS-PAGE. Separated proteins were electroblotted onto nitrocellulose paper and processed as described m Section 2 
in the presence of - I mM free Ca” (7) and in the absence of Ca’+ (8f, The CaBP33-CaBP37 mixture bound to cytoskefeton poiypeptides was 
evidenced with the aid of the anti-CaBP33XaBP37 antiserum. Asterisks pomt to the posittons of cytoskeleton poiypeptrdes with ability to bind 
the CaBP33-CaBP37 mixture. 
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might have escaped detection because of dissociation of 
the two annexins from these binding sites as a conse- 
quence of the numerous passages and washings inherent 
to the overall procedure employed. If so, then the con- 
clusion could be reasonably drawn that the binding of 
the CaBP33-CaBP37 mixture to the lo-20 kDa and to 
the 110 kDa polypeptides is of relatively high affinity 
and/or capacity, also in consideration of the concentra- 
tion (- 0.3 ,uM) of the annexin’s mixture in the binding 
assay. Moreover, it is possible that other CaBP33- 
CaBP37-binding polypeptides have not been detected 
because of non-renaturation after transfer and immo- 
bilization onto the nitrocellulose membrane. Analyses 
of the CaBP33-CaBP37-binding proteins in cytoske- 
letons by affinity chromatography will hopefully 
elucidate these points. On the basis of the data in Fig. 5, 
lane 7, the 85-90 kDa complex detected by immuno- 
blotting in cross-linking experiments probably results 
from binding of one or both annexins to the low M, 
polypeptides shown to bind the CaBP33-CaBP37 mix- 
ture in the overlay experiments. 
Altogether, the present data suggest that CaBP33 and 
CaBP37 bind to a set of cytoskeleton proteins Ca*+-de- 
pendently with a relatively high affinity and, hence, 
that membrane-associated proteins, besides acidic 
phospholipids in the membrane bilayer, could be 
targets of these two annexins. Within the limits of the 
techniques used in this and the previous [2] studies, it 
seems that the CaBP33-CaBP37 mixture would 
preferentially bind to the lipid bilayer at the free Ca*+ 
concentrations found within cells upon appropriate ac- 
tivation, since half-maximal binding to acidic 
phopholipids occurs at - 10 PM [2], whereas half- 
maximal binding to cytoskeleton proteins occurs at 
significantly larger free Ca2+ concentrations, in vitro. 
However, it is possible that some unknown factor(s) 
might stabilize the interactions of these two annexins 
with the cytoskeleton and/or stimulate these interac- 
tions at physiological free Ca’+ concentrations. 
Preliminary data indicate that in rat cerebellum and 
sciatic nerves, where only CaBP33 is expressed [2], 
CaBP33 is restricted to glial cells (in preparation). 
Future studies using cultured glial cells will help to 
elucidate both the identity of cytoskeleton proteins that 
are targets of these two annexins and the nature of fac- 
tors, including the free Ca2+ concentration, that 
regulate the association of CaBP33 and CaBP37 with 
membranes. 
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